Treated animals regained normal gait patterns (measured by Walking Recovery Index and Motor Function Index), reversed limb contracture, and preserved muscle diameter, while control animals developed permanent deficits and progressive atrophy
[3] [17] The American Diabetes Association's Standards of Care emphasizes the importance of patient education regarding these potential adverse effects and appropriate monitoring during treatment initiation and dose titration
-Qu sucede cuando hay una interrupcin del tratamiento
J Diabetes Invest
- Middle Asian, African black skin patients need more sessions to get brigetening effect, must have a consultation with Dermatologist
Well, the existing data do not show that. Patients often stop using GLP-1s within a year for a variety of reasons, including cost, meeting their goal weight or gastrointestinal side effects